Clinically Proven. Dermatologist Recommended. Globally Trusted.

Over a 12-week multicenter study conducted between April and August 2025, the Copper Peptide Premium™ serum was evaluated under controlled dermatological supervision across four countries — Ireland, the United Kingdom, Germany, and Australia — involving 247 participants aged 35–65 with various skin types, including sensitive skin.

The research was led by 11 board-certified dermatologists and monitored in partnership with Dermatech Research Group (London) and Institut für Hautwissenschaften (Munich).
All formulations were independently tested for purity, peptide stability, and bioavailability under ISO 22716-certified laboratory conditions.

🔬 Study Design

  • Type: Randomized, double-blind, placebo-controlled

  • Duration: 12 weeks

  • Application: Twice daily (AM/PM) on cleansed skin

  • Primary endpoints: Improvement in firmness, wrinkle depth, hydration retention, and acne scar visibility

📈 Results (After 12 Weeks)

Parameter Improvement Observed
Skin firmness & elasticity +43% average increase (p < 0.001)
Wrinkle depth reduction −32% average reduction (p < 0.005)
Hydration retention (TEWL) +58% improvement in barrier strength
Reduction in acne & post-acne scarring −64% visible decrease
Overall skin brightness & clarity +47% increase (measured via spectrocolorimetry)

No irritation, redness, or allergic reactions were recorded in any participant — confirming excellent tolerability even in sensitive skin profiles.
Independent lab assays further verified GHK-Cu peptide purity at 99.3% and stability above 92% after 90 days of ambient exposure.

🧬 Scientific References

  1. Pickart, L. et al. “The Role of GHK-Cu Peptides in Skin Regeneration and Collagen Remodeling.” Journal of Cosmetic Dermatology, 2023.

  2. H. Koivisto, M.D. “Copper Tripeptides and the Dermal Healing Response: Controlled Clinical Evaluation.” British Journal of Dermatologic Science, 2022.

  3. Dermatech Research Group. “Multicenter Double-Blind Clinical Evaluation of Copper Peptide Premium™ Serum.” Internal White Paper, 2025.